1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Diffuse Large B-Cell Lymphoma Unclassifiable: new trials by email Literature Review of Diffuse Large B-Cell Lymphoma Unclassifiable trials Research Report on Diffuse Large B-Cell Lymphoma Unclassifiable
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - Diffuse Large B-Cell Lymphoma Unclassifiable | Phase 2 | Completed | M.D. Anderson Cancer Center | 60 | 2016-03-29 | 2024-03-13 |
CT-P10 (1) · Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Lenalidomide (1) · Prednisone (1) · Rituximab (1) · Vincristine (1) · deltacortene (1) · ibrutinib (1) · prednylidene (1)
M.D. Anderson Cancer Center (1)
United States (1)
Jason Westin (1)